Caiming Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caiming Li has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Wenbin Du
State Key Laboratory of Microbial Resources, Institute of Microbiology Chinese Academy of Sciences Beijing China
4 shared publications Yuchen Li
3 shared publicationsHaiwei Qiu
2 shared publications- Limin Yang
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China
2 shared publications Liyan Ma
2 shared publicationsShuilong Guo
2 shared publications
Latest Publications
- Open Access
- 29 May 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (6)
Unveiling Neonatal Pneumonia Microbiome by High-throughput Sequencing and Droplet Culturomics
Neonatal pneumonia is a leading cause of infant mortality worldwide; however, a lack of microbial profiling, especially of low-abundance species, makes accurate diagnosis challenging. Traditional methods can fail to capture the complexity of the neonatal respiratory microbiota, thereby obscuring its role in disease progression. Here, we describe a novel approach that combines high-throughput sequencing with droplet-based microfluidic cultivation to investigate microbiome shifts in neonates with pneumonia. Using 16S ribosomal RNA (rRNA) gene sequencing of 71 pneumonia cases and 49 controls, we identified 1009 genera, including 930 low-abundance taxa, which showed significant compositional differences between groups. Linear discriminant analysis effect size identified key pneumonia-associated genera, such as Streptococcus, Rothia, and Corynebacterium. Droplet-based cultivation recovered 299 strains from 94 taxa, including rare species and ESKAPE pathogens, thereby supporting targeted antimicrobial management. Host–pathogen interaction assays showed that Rothia and Corynebacterium induced inflammation in lung epithelial cells, likely via dysregulation of the PI3K-Akt pathway. Integrating these marker taxa with clinical factors, such as gestational age and delivery type, offers the potential for precise diagnosis and treatment. The recovery of diverse species can support the construction of a biobank of neonatal respiratory microbiota to advance mechanistic studies and therapeutic strategies.
- 29 May 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (6)
Open AccessUnveiling Neonatal Pneumonia Microbiome by High-throughput Sequencing and Droplet Culturomics
Neonatal pneumonia is a leading cause of infant mortality worldwide; however, a lack of microbial profiling, especially of low-abundance species, makes accurate diagnosis challenging. Traditional methods can fail to capture the complexity of the neonatal respiratory microbiota, thereby obscuring its role in disease progression. Here, we describe a novel approach that combines high-throughput sequencing with droplet-based microfluidic cultivation to investigate microbiome shifts in neonates with pneumonia. Using 16S ribosomal RNA (rRNA) gene sequencing of 71 pneumonia cases and 49 controls, we identified 1009 genera, including 930 low-abundance taxa, which showed significant compositional differences between groups. Linear discriminant analysis effect size identified key pneumonia-associated genera, such as Streptococcus, Rothia, and Corynebacterium. Droplet-based cultivation recovered 299 strains from 94 taxa, including rare species and ESKAPE pathogens, thereby supporting targeted antimicrobial management. Host–pathogen interaction assays showed that Rothia and Corynebacterium induced inflammation in lung epithelial cells, likely via dysregulation of the PI3K-Akt pathway. Integrating these marker taxa with clinical factors, such as gestational age and delivery type, offers the potential for precise diagnosis and treatment. The recovery of diverse species can support the construction of a biobank of neonatal respiratory microbiota to advance mechanistic studies and therapeutic strategies.
- Open Access
- 22 March 2024
- Published by Wiley in Advanced Science
- Vol. 11 (21) , 2309557
All‐In‐One OsciDrop Digital PCR System for Automated and Highly Multiplexed Molecular Diagnostics
Digital PCR (dPCR) holds immense potential for precisely detecting nucleic acid markers essential for personalized medicine. However, its broader application is hindered by high consumable costs, complex procedures, and restricted multiplexing capabilities. To address these challenges, an all‐in‐one dPCR system is introduced that eliminates the need for microfabricated chips, offering fully automated operations and enhanced multiplexing capabilities. Using this innovative oscillation‐induced droplet generation technique, OsciDrop, this system supports a comprehensive dPCR workflow, including precise liquid handling, pipette‐based droplet printing, in situ thermocycling, multicolor fluorescence imaging, and machine learning‐driven analysis. The system's reliability is demonstrated by quantifying reference materials and evaluating HER2 copy number variation in breast cancer. Its multiplexing capability is showcased with a quadruplex dPCR assay that detects key EGFR mutations, including 19Del, L858R, and T790M in lung cancer. Moreover, the digital stepwise melting analysis (dSMA) technique is introduced, enabling high‐multiplex profiling of seven major EGFR variants spanning 35 subtypes. This innovative dPCR system presents a cost‐effective and versatile alternative, overcoming existing limitations and paving the way for transformative advances in precision diagnostics.
- 22 March 2024
- Published by Wiley in Advanced Science
- Vol. 11 (21) , 2309557
Open AccessAll‐In‐One OsciDrop Digital PCR System for Automated and Highly Multiplexed Molecular Diagnostics
Digital PCR (dPCR) holds immense potential for precisely detecting nucleic acid markers essential for personalized medicine. However, its broader application is hindered by high consumable costs, complex procedures, and restricted multiplexing capabilities. To address these challenges, an all‐in‐one dPCR system is introduced that eliminates the need for microfabricated chips, offering fully automated operations and enhanced multiplexing capabilities. Using this innovative oscillation‐induced droplet generation technique, OsciDrop, this system supports a comprehensive dPCR workflow, including precise liquid handling, pipette‐based droplet printing, in situ thermocycling, multicolor fluorescence imaging, and machine learning‐driven analysis. The system's reliability is demonstrated by quantifying reference materials and evaluating HER2 copy number variation in breast cancer. Its multiplexing capability is showcased with a quadruplex dPCR assay that detects key EGFR mutations, including 19Del, L858R, and T790M in lung cancer. Moreover, the digital stepwise melting analysis (dSMA) technique is introduced, enabling high‐multiplex profiling of seven major EGFR variants spanning 35 subtypes. This innovative dPCR system presents a cost‐effective and versatile alternative, overcoming existing limitations and paving the way for transformative advances in precision diagnostics.
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Point-of-Care Detection of Mycobacterium In Bovine Feces Using a Portable Real-Time Loop-Mediated Isothermal Amplification System
Rapid diagnosis at the point of care is needed to protect the health of animals and humans susceptible through infections with zoonotic diseases. Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of bovine paratuberculosis in ruminants and Crohn's disease in humans, presents a significant challenge for in situ diagnostics. This study reports a low-cost 'sample-to-result' detection system designed for the sensitive and specific detection of MAP in bovine feces. The portable system incorporates 3D-printed components, including a thermal lysis incubator, adjustable isothermal block, and real-time fluorescence detector, offering robust performance with precise temperature control and real-time detection for four standard PCR tubes. The optimized qLAMP assay, targetting the F57 gene of MAP with a 20-minute amplification time and threshold times under 5 minutes for positive samples. A miniaturized FTA (μFTA) card was introduced for streamlined DNA extraction and real-time loop-mediated isothermal amplification (qLAMP) without the elution step, offering enhanced sensitivity through DNA enrichment via the μFTA card. Compared to standard qPCR and magenatic beads based DNA extraction, our portable qLAMP system exhibit superior inhibitor tolerance (IC50 of 5.87% vs. 0.20%) for feces residues, achieving an ultralow detection limit of ~10 CFU/mL. Integrating μFTA cards with portable qLAMP amplifier improves the system's robustness and practicality for field diagnostics, making it well-suited for applications in resource-limited settings, food safety, epidemiological studies, and clinical diagnostics.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessPoint-of-Care Detection of Mycobacterium In Bovine Feces Using a Portable Real-Time Loop-Mediated Isothermal Amplification System
Rapid diagnosis at the point of care is needed to protect the health of animals and humans susceptible through infections with zoonotic diseases. Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of bovine paratuberculosis in ruminants and Crohn's disease in humans, presents a significant challenge for in situ diagnostics. This study reports a low-cost 'sample-to-result' detection system designed for the sensitive and specific detection of MAP in bovine feces. The portable system incorporates 3D-printed components, including a thermal lysis incubator, adjustable isothermal block, and real-time fluorescence detector, offering robust performance with precise temperature control and real-time detection for four standard PCR tubes. The optimized qLAMP assay, targetting the F57 gene of MAP with a 20-minute amplification time and threshold times under 5 minutes for positive samples. A miniaturized FTA (μFTA) card was introduced for streamlined DNA extraction and real-time loop-mediated isothermal amplification (qLAMP) without the elution step, offering enhanced sensitivity through DNA enrichment via the μFTA card. Compared to standard qPCR and magenatic beads based DNA extraction, our portable qLAMP system exhibit superior inhibitor tolerance (IC50 of 5.87% vs. 0.20%) for feces residues, achieving an ultralow detection limit of ~10 CFU/mL. Integrating μFTA cards with portable qLAMP amplifier improves the system's robustness and practicality for field diagnostics, making it well-suited for applications in resource-limited settings, food safety, epidemiological studies, and clinical diagnostics.